Millennium Capital Advisors LLC purchased a new stake in Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 4,063 shares of the company’s stock, valued at approximately $648,000.
A number of other institutional investors have also recently modified their holdings of LABU. Qube Research & Technologies Ltd purchased a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares in the second quarter valued at approximately $26,000. Headlands Technologies LLC purchased a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares in the second quarter valued at approximately $69,000. Bank of America Corp DE boosted its stake in shares of Direxion Daily S&P Biotech Bull 3x Shares by 134.2% in the third quarter. Bank of America Corp DE now owns 2,476 shares of the company’s stock valued at $232,000 after buying an additional 1,419 shares in the last quarter. Group One Trading LLC purchased a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares in the third quarter valued at approximately $349,000. Finally, CIBC Private Wealth Group LLC purchased a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares in the third quarter valued at approximately $351,000.
Direxion Daily S&P Biotech Bull 3x Shares Stock Performance
Direxion Daily S&P Biotech Bull 3x Shares stock opened at $172.57 on Friday. Direxion Daily S&P Biotech Bull 3x Shares has a 1-year low of $47.53 and a 1-year high of $212.45. The stock’s 50 day moving average price is $173.84 and its 200 day moving average price is $163.71.
About Direxion Daily S&P Biotech Bull 3x Shares
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
Read More
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- 3 Stocks to Own If Gas Prices Keep Rising
- 3 Crucial Aerospace Component Makers That Analysts Love
- Alphabet’s Googlebook Brings Gemini AI to PC Hardware
- Peloton Stock Gives Back Gains After Upbeat Earnings Report
Want to see what other hedge funds are holding LABU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Free Report).
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.
